Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT06268613
Title A Study to Compare the Pharmacokinetics, Efficacy, Safety, and Immunogenicity of Pembrolizumab (SB27, EU Sourced Keytruda, and US Sourced Keytruda) in Subjects With Stage II-IIIA NSCLC Following Complete Resection and Adjuvant Platinum-based Chemotherapy
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Samsung Bioepis Co., Ltd.
Indications
Therapies
Age Groups: adult | senior
Covered Countries ESP

Facility Status City State Zip Country Details
SB Investigative Site RECRUITING Busan Korea, Republic of Details
SB Investigative Site RECRUITING Daegu Korea, Republic of Details
SB Investigative Site RECRUITING Hwasun Korea, Republic of Details
SB Investigative Site RECRUITING Jinju Korea, Republic of Details
SB Investigative Site RECRUITING Seongnam Korea, Republic of Details
SB Investigative Site RECRUITING Seoul Korea, Republic of Details
SB Investigative Site RECRUITING Suwon Korea, Republic of Details
SB Investigative Site RECRUITING Szczecin Poland Details
SB Investigative Site RECRUITING Leganés Madrid Spain Details
SB Investigative Site RECRUITING A Coruña Santiago De Compostela Spain Details
SB Investigative Site RECRUITING Jaén Spain Details
SB Investigative Site RECRUITING Málaga Spain Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field